tradingkey.logo

Teleflex Inc

TFX
108.420USD
+2.600+2.46%
Fechamento 02/06, 16:00ETCotações atrasadas em 15 min
4.79BValor de mercado
PerdaP/L TTM

Mais detalhes de Teleflex Inc Empresa

Teleflex Incorporated is a global provider of medical technologies. The Company offers a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. It primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. It operates in three segments: the Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). Its vascular access product portfolio includes Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous (bone access) systems. Its interventional product offerings consist of a portfolio of Arrow branded intra-aortic balloon pumps and catheters, GuideLiner, Turnpike and TrapLiner catheters, Pulsar-18 T3 Self-Expanding 4F Stent and Orsiro Mission Drug Eluting Stent.

Informações de Teleflex Inc

Código da empresaTFX
Nome da EmpresaTeleflex Inc
Data de listagemMar 17, 1980
CEOKelly (Liam J)
Número de funcionários14100
Tipo de títulosOrdinary Share
Fim do ano fiscalMar 17
Endereço550 E Swedesford Rd
CidadeWAYNE
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal19087
Telefone16102256800
Sitehttps://www.teleflex.com/usa/en/#
Código da empresaTFX
Data de listagemMar 17, 1980
CEOKelly (Liam J)

Executivos da empresa Teleflex Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Liam J. Kelly
Mr. Liam J. Kelly
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
50.99K
+1500.00%
Mr. Stuart Allen (Stu) Randle
Mr. Stuart Allen (Stu) Randle
Independent Director
Independent Director
22.55K
+12325.00%
Mr. Cameron P. Hicks
Mr. Cameron P. Hicks
Corporate Vice President - Human Resources and Communications
Corporate Vice President - Human Resources and Communications
10.38K
+1162.00%
Dr. Stephen K. Klasko, M.D.
Dr. Stephen K. Klasko, M.D.
Lead Independent Director
Lead Independent Director
10.06K
+1357.00%
Mr. Andrew A. (Andy) Krakauer
Mr. Andrew A. (Andy) Krakauer
Independent Director
Independent Director
6.54K
+1000.00%
Ms. Gretchen R. Haggerty
Ms. Gretchen R. Haggerty
Independent Director
Independent Director
5.66K
+500.00%
Mr. John C. Heinmiller
Mr. John C. Heinmiller
Independent Director
Independent Director
4.39K
+1051.00%
Dr. Jaewon Ryu, M.D., J.D.
Dr. Jaewon Ryu, M.D., J.D.
Independent Director
Independent Director
3.08K
+1500.00%
Ms. Neena M. Patil, J.D.
Ms. Neena M. Patil, J.D.
Independent Director
Independent Director
1.98K
+1051.00%
Ms. Candace H. Duncan
Ms. Candace H. Duncan
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Liam J. Kelly
Mr. Liam J. Kelly
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
50.99K
+1500.00%
Mr. Stuart Allen (Stu) Randle
Mr. Stuart Allen (Stu) Randle
Independent Director
Independent Director
22.55K
+12325.00%
Mr. Cameron P. Hicks
Mr. Cameron P. Hicks
Corporate Vice President - Human Resources and Communications
Corporate Vice President - Human Resources and Communications
10.38K
+1162.00%
Dr. Stephen K. Klasko, M.D.
Dr. Stephen K. Klasko, M.D.
Lead Independent Director
Lead Independent Director
10.06K
+1357.00%
Mr. Andrew A. (Andy) Krakauer
Mr. Andrew A. (Andy) Krakauer
Independent Director
Independent Director
6.54K
+1000.00%
Ms. Gretchen R. Haggerty
Ms. Gretchen R. Haggerty
Independent Director
Independent Director
5.66K
+500.00%

Detalhamento da receita

Moeda: USDAtualizado em: ter, 6 de jan
Moeda: USDAtualizado em: ter, 6 de jan
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Por EmpresaUSD
Nome
Receita
Proporção
Interventional
266.41M
29.18%
Vascular access
191.02M
20.92%
Surgical
122.88M
13.46%
Anesthesia
101.45M
11.11%
OEM
80.41M
8.81%
Outro
150.85M
16.52%
Por RegiãoUSD
Nome
Receita
Proporção
Americas
555.90M
60.89%
EMEA
234.25M
25.66%
Asia Pacific
122.87M
13.46%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Interventional
266.41M
29.18%
Vascular access
191.02M
20.92%
Surgical
122.88M
13.46%
Anesthesia
101.45M
11.11%
OEM
80.41M
8.81%
Outro
150.85M
16.52%

Distribuição de ações

Atualizado em: qui, 29 de jan
Atualizado em: qui, 29 de jan
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
BlackRock Institutional Trust Company, N.A.
11.05%
The Vanguard Group, Inc.
10.72%
T. Rowe Price Investment Management, Inc.
10.34%
Janus Henderson Investors
9.42%
AQR Capital Management, LLC
5.35%
Outro
53.12%
Investidores
Investidores
Proporção
BlackRock Institutional Trust Company, N.A.
11.05%
The Vanguard Group, Inc.
10.72%
T. Rowe Price Investment Management, Inc.
10.34%
Janus Henderson Investors
9.42%
AQR Capital Management, LLC
5.35%
Outro
53.12%
Tipos de investidores
Investidores
Proporção
Investment Advisor
57.71%
Investment Advisor/Hedge Fund
35.62%
Hedge Fund
9.18%
Pension Fund
1.88%
Sovereign Wealth Fund
1.36%
Research Firm
0.92%
Bank and Trust
0.58%
Family Office
0.45%
Individual Investor
0.37%

Participação acionária institucional

Atualizado em: qui, 1 de jan
Atualizado em: qui, 1 de jan
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q4
1166
47.10M
106.57%
-2.12M
2025Q3
1153
47.10M
106.58%
-5.30M
2025Q2
1158
48.67M
110.13%
-386.02K
2025Q1
1189
48.85M
110.52%
-721.30K
2024Q4
1180
47.47M
102.37%
-260.40K
2024Q3
1150
46.34M
98.36%
-1.83M
2024Q2
1147
46.98M
99.75%
-268.09K
2024Q1
1153
46.02M
97.70%
-1.89M
2023Q4
1170
46.05M
97.91%
-2.57M
2023Q3
1173
45.95M
97.77%
-3.19M
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
BlackRock Institutional Trust Company, N.A.
4.89M
11.05%
-86.30K
-1.74%
Sep 30, 2025
The Vanguard Group, Inc.
4.78M
10.81%
-20.71K
-0.43%
Sep 30, 2025
T. Rowe Price Investment Management, Inc.
4.57M
10.34%
-1.38M
-23.14%
Sep 30, 2025
Janus Henderson Investors
4.16M
9.42%
+12.09K
+0.29%
Sep 30, 2025
AQR Capital Management, LLC
2.37M
5.35%
+1.96M
+478.06%
Sep 30, 2025
Atlanta Capital Management Company, L.L.C.
2.30M
5.21%
-103.20K
-4.29%
Sep 30, 2025
State Street Investment Management (US)
1.46M
3.3%
-3.02K
-0.21%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
1.25M
2.82%
+3.81K
+0.31%
Sep 30, 2025
Cooke & Bieler, L.P.
1.22M
2.76%
+14.67K
+1.22%
Sep 30, 2025
Abrams Bison Investments, L.L.C.
917.92K
2.08%
+917.92K
--
Sep 30, 2025
Ver Mais

ETFs Relacionados

Atualizado em: sáb, 6 de dez
Atualizado em: sáb, 6 de dez
Nome
Proporção
Invesco S&P SmallCap Health Care ETF
3.37%
First Trust Indxx Medical Devices ETF
2.09%
First Trust Health Care Alphadex Fund
1.77%
State Street SPDR S&P Health Care Equipment ETF
1.7%
Zacks Small/Mid Cap ETF
0.85%
State Street SPDR S&P 600 Small Cap Value ETF
0.75%
iShares S&P Small-Cap 600 Value ETF
0.75%
Distillate Small/Mid Cash Flow ETF
0.7%
VictoryShares Small Cap Free Cash Flow ETF
0.68%
iShares MSCI USA Small-Cap Min Vol Factor ETF
0.67%
Ver Mais
Invesco S&P SmallCap Health Care ETF
Proporção3.37%
First Trust Indxx Medical Devices ETF
Proporção2.09%
First Trust Health Care Alphadex Fund
Proporção1.77%
State Street SPDR S&P Health Care Equipment ETF
Proporção1.7%
Zacks Small/Mid Cap ETF
Proporção0.85%
State Street SPDR S&P 600 Small Cap Value ETF
Proporção0.75%
iShares S&P Small-Cap 600 Value ETF
Proporção0.75%
Distillate Small/Mid Cash Flow ETF
Proporção0.7%
VictoryShares Small Cap Free Cash Flow ETF
Proporção0.68%
iShares MSCI USA Small-Cap Min Vol Factor ETF
Proporção0.67%

Dividendo

Um total de 254.87M USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Nov 06, 2025
TFX.NB Final Cash Dividend of gross USD 0.34 paid on Dec 15, 2025 going ex on Nov 14, 2025
Nov 14, 2025
Dec 15, 2025
Nov 14, 2025
Jul 31, 2025
TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Sep 15, 2025 going ex on Aug 15, 2025
Aug 15, 2025
Sep 15, 2025
Aug 15, 2025
May 12, 2025
TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Jun 16, 2025 going ex on May 20, 2025
May 20, 2025
Jun 16, 2025
May 20, 2025
Feb 27, 2025
TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Mar 17, 2025 going ex on Mar 07, 2025
Mar 07, 2025
Mar 17, 2025
Mar 07, 2025
Oct 31, 2024
TFX.NB Final Cash Dividend of gross USD 0.34 paid on Dec 16, 2024 going ex on Nov 15, 2024
Nov 15, 2024
Dec 16, 2024
Nov 15, 2024
Aug 01, 2024
TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Sep 16, 2024 going ex on Aug 15, 2024
Aug 15, 2024
Sep 16, 2024
Aug 15, 2024
May 06, 2024
TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Jun 14, 2024 going ex on May 14, 2024
May 15, 2024
Jun 14, 2024
May 14, 2024
Feb 22, 2024
TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Mar 15, 2024 going ex on Feb 29, 2024
Mar 01, 2024
Mar 15, 2024
Feb 29, 2024
Nov 02, 2023
TFX.NB Final Cash Dividend of gross USD 0.34 paid on Dec 15, 2023 going ex on Nov 14, 2023
Nov 15, 2023
Dec 15, 2023
Nov 14, 2023
Aug 03, 2023
TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Sep 15, 2023 going ex on Aug 14, 2023
Aug 15, 2023
Sep 15, 2023
Aug 14, 2023
Ver Mais

Desdobramento de ações

Data
Data ex-dividendo
Tipo
Proporção
Sem dados
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
KeyAI